ANR54_HUMAN - dbPTM
ANR54_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ANR54_HUMAN
UniProt AC Q6NXT1
Protein Name Ankyrin repeat domain-containing protein 54
Gene Name ANKRD54
Organism Homo sapiens (Human).
Sequence Length 300
Subcellular Localization Nucleus. Cytoplasm. Midbody. Shuttles between nucleus and cytoplasm during the cell cycle. EPO stimulation induces nuclear accumulation (By similarity)..
Protein Description Plays an important role in regulating intracellular signaling events associated with erythroid terminal differentiation..
Protein Sequence MAAAAGDADDEPRSGHSSSEGECAVAPEPLTDAEGLFSFADFGSALGGGGAGLSGRASGGAQSPLRYLHVLWQQDAEPRDELRCKIPAGRLRRAARPHRRLGPTGKEVHALKRLRDSANANDVETVQQLLEDGADPCAADDKGRTALHFASCNGNDQIVQLLLDHGADPNQRDGLGNTPLHLAACTNHVPVITTLLRGGARVDALDRAGRTPLHLAKSKLNILQEGHAQCLEAVRLEVKQIIHMLREYLERLGQHEQRERLDDLCTRLQMTSTKEQVDEVTDLLASFTSLSLQMQSMEKR
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAAAAGDAD
------CCCCCCCCC
13.0519413330
6 (in isoform 2)Phosphorylation-26.3924043423
7 (in isoform 2)Phosphorylation-41.9429116813
13 (in isoform 2)Phosphorylation-53.9029116813
14PhosphorylationDADDEPRSGHSSSEG
CCCCCCCCCCCCCCC
52.1224144214
17PhosphorylationDEPRSGHSSSEGECA
CCCCCCCCCCCCCEE
38.8024144214
18PhosphorylationEPRSGHSSSEGECAV
CCCCCCCCCCCCEEE
27.0824144214
19PhosphorylationPRSGHSSSEGECAVA
CCCCCCCCCCCEEEC
53.2724144214
31PhosphorylationAVAPEPLTDAEGLFS
EECCCCCCCCCCCCC
43.8324144214
38PhosphorylationTDAEGLFSFADFGSA
CCCCCCCCHHHHHHC
25.2724144214
44PhosphorylationFSFADFGSALGGGGA
CCHHHHHHCCCCCCC
21.9524144214
54PhosphorylationGGGGAGLSGRASGGA
CCCCCCCCCCCCCCC
25.8924144214
58PhosphorylationAGLSGRASGGAQSPL
CCCCCCCCCCCCCHH
36.0823927012
63PhosphorylationRASGGAQSPLRYLHV
CCCCCCCCHHHHHHH
25.9329255136
67PhosphorylationGAQSPLRYLHVLWQQ
CCCCHHHHHHHHHHC
14.6122199227
85UbiquitinationPRDELRCKIPAGRLR
CCHHHCCCCCHHHHH
45.3429967540
90MethylationRCKIPAGRLRRAARP
CCCCCHHHHHHHCCC
27.42-
106UbiquitinationRRLGPTGKEVHALKR
CCCCCCHHHHHHHHH
60.0733845483
106AcetylationRRLGPTGKEVHALKR
CCCCCCHHHHHHHHH
60.0726051181
112UbiquitinationGKEVHALKRLRDSAN
HHHHHHHHHHHHCCC
50.6129967540
142UbiquitinationDPCAADDKGRTALHF
CCCCCCCCCCEEEEE
51.3329967540
217UbiquitinationRTPLHLAKSKLNILQ
CCHHHHHHHHHHHHH
55.2633845483
217AcetylationRTPLHLAKSKLNILQ
CCHHHHHHHHHHHHH
55.2625953088
218PhosphorylationTPLHLAKSKLNILQE
CHHHHHHHHHHHHHH
36.4582900693
219UbiquitinationPLHLAKSKLNILQEG
HHHHHHHHHHHHHHH
44.8629967540
239AcetylationEAVRLEVKQIIHMLR
HHHHHHHHHHHHHHH
26.8025953088
266PhosphorylationERLDDLCTRLQMTST
HHHHHHHHHHHCCCC
41.5324275569
271PhosphorylationLCTRLQMTSTKEQVD
HHHHHHCCCCHHHHH
21.9324275569
286PhosphorylationEVTDLLASFTSLSLQ
HHHHHHHHHHHHHHH
29.0924275569
288PhosphorylationTDLLASFTSLSLQMQ
HHHHHHHHHHHHHHH
26.6824275569
289PhosphorylationDLLASFTSLSLQMQS
HHHHHHHHHHHHHHH
17.6024275569

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of ANR54_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ANR54_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ANR54_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of ANR54_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ANR54_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63, AND MASSSPECTROMETRY.

TOP